Zobrazeno 1 - 8
of 8
pro vyhledávání: '"E O, Korobkova"'
Autor:
M. V. Kozhevnikova, E. O. Korobkova, A. V. Krivova, A. V. Kukharenko, N. E. Moskaleva, K. M. Shestakova, N. V. Mesonzhnik, A. A. Ageev, A. A. Boldin, A. Brito, S. А. Appolonova, E. V. Privalova, Y. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 230-239 (2023)
Aim. Branched-chain amino acids (BCAAs) have been postulated as potential indicators of cardiovascular risk. The objective of this study was to explore the relationship between plasma BCAAs and different stages of cardiovascular disorders.Material an
Externí odkaz:
https://doaj.org/article/61c3c7ab4d554143906bdba8748d9c90
Autor:
A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 3, Pp 297-305 (2022)
Aim. To evaluate changes in the profile of aromatic amino acids (AAA) in patients with cardiovascular diseases (CVD): hypertension and coronary artery disease (CАD) in comparison with healthy study participants.Material and methods. One hundred and
Externí odkaz:
https://doaj.org/article/635f8136ef1b4717b3c5152341bfb1f8
Autor:
M. V. Kozhevnikova, A. V. Krivova, E. O. Korobkova, A. A. Ageev, K. M. Shestakova, N. E. Moskaleva, S. A. Appolonova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Kardiologiia. 62:40-48
Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD).Material and methods This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c1b3608ed989bc5463cb8cadfc3818
https://doi.org/10.18087/cardio.2022.11.n2283
https://doi.org/10.18087/cardio.2022.11.n2283
Autor:
A. S. Lishuta, V. Yu. Kaplunova, E O Korobkova, Yu N Belenkov, G. A. Shakaryants, M V Kozhevnikova, E. V. Privalova
Publikováno v:
Kardiologiia. 60:120-129
This review presents major directions in studies of myocardial hypertrophy from the aspect of transcriptomics and metabolomics. Understanding of trigger mechanisms of myocardial hypertrophy will permit transition from basic studies to individualized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0f72ea67f1bf559ffc24ab550e79c3
https://doi.org/10.18087/cardio.2020.4.n1063
https://doi.org/10.18087/cardio.2020.4.n1063
Autor:
Yu N Belenkov, Yu I Naymann, I S Ilgisonis, A M Lyamin, N V Ogorodnikov, N V Khabarova, E O Korobkova, E. V. Privalova, M V Kozhevnikova, Yu Yu Kirichenko
Publikováno v:
Kardiologiia. 60:89-95
Objective. To evaluate and study the dynamics of endothelial dysfunction instrumental indicators, vascular wall stiffness and microcirculation state in patients with gastric cancer (adenocarcinoma) before and after chemotherapy; compare it with the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586a1f9eee298b28b6f16887aca35d0c
https://doi.org/10.18087/cardio.2020.2.n908
https://doi.org/10.18087/cardio.2020.2.n908
Autor:
E O Korobkova, G. A. Shakaryants, E V Larcova, Svetlana A. Appolonova, N V Mesonzhik, I S Ilgisonis, E. V. Privalova, Y N Belenkov, V. Y. Kaplunova, A V Kuharenko, M V Kozhevnikova
Publikováno v:
Scopus-Elsevier
Cardiovascular diseases (CVD) are the main cause of death worldwide. A broad study of the pathogenetic mechanisms of the CVD onset and progression has led to understanding of the importance of endothelial dysfunction (ED) in these processes. During r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82798c6dc2b23439d972fc7524c703a1
https://doi.org/10.18087/cardio.2018.9.10172
https://doi.org/10.18087/cardio.2018.9.10172
Autor:
E V Larcova, Yu N Belenkov, A A Maltseva, E O Korobkova, N V Khabarova, I S Ilgisonis, G. A. Shakaryants, M V Kozhevnikova, Alexey Kukharenko, Svetlana A. Appolonova
Publikováno v:
Kardiologiia. 60(3)
Objective. To identify biomarkers, which are most specific for patients with metabolic syndrome (MS) using metabolomic profiling.Materials and Methods. Metabolomic profiling of patients with MS and comparison of their profile with the profile of volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c458e7dc11a68886789f083eee76b94
https://pubmed.ncbi.nlm.nih.gov/32375614
https://pubmed.ncbi.nlm.nih.gov/32375614
Autor:
Y N, Belenkov, E V, Privalova, M V, Kozhevnikova, E O, Korobkova, I S, Ilgisonis, V Y, Kaplunova, G A, SHakaryants, S A, Appolonova, A V, Kuharenko, E V, Larcova, N V, Mesonzhik
Publikováno v:
Kardiologiia. 58(9)
Cardiovascular diseases (CVD) are the main cause of death worldwide. A broad study of the pathogenetic mechanisms of the CVD onset and progression has led to understanding of the importance of endothelial dysfunction (ED) in these processes. During r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95c2a46fc8469a58295a3c6dd1d45645
https://pubmed.ncbi.nlm.nih.gov/30295200
https://pubmed.ncbi.nlm.nih.gov/30295200